Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations, aiming to delay disease progression. The study was presented by...
Turfan Leads the Way: Electricity Drives Development of Smart Irrigation Demonstration Zone
TURFAN, China, Nov. 22, 2024 /PRNewswire/ -- On November 19, State Grid Turfan Power Supply Company personnel conducted a site inspection at a 329-acre grape water-saving smart irrigation demonstration zone in Gaochang District. During the visit,...